These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9681463)

  • 1. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease.
    Sberna G; Sáez-Valero J; Li QX; Czech C; Beyreuther K; Masters CL; McLean CA; Small DH
    J Neurochem; 1998 Aug; 71(2):723-31. PubMed ID: 9681463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition.
    Fodero LR; Sáez-Valero J; McLean CA; Martins RN; Beyreuther K; Masters CL; Robertson TA; Small DH
    J Neurochem; 2002 May; 81(3):441-8. PubMed ID: 12065653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
    Arendt T; Brückner MK; Lange M; Bigl V
    Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell lines.
    Hicks DA; Makova NZ; Gough M; Parkin ET; Nalivaeva NN; Turner AJ
    J Biol Chem; 2013 Sep; 288(36):26039-26051. PubMed ID: 23897820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AChE and the amyloid precursor protein (APP) - Cross-talk in Alzheimer's disease.
    Nalivaeva NN; Turner AJ
    Chem Biol Interact; 2016 Nov; 259(Pt B):301-306. PubMed ID: 27062894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of electroacupuncture on the behavior and the expression of amyloid beta-protein, amyloid precursor protein and ChAT in APP 695 V 717 I transgenic mice].
    Xue WG; Zhang Z; Bai LM; Xu H; Wu HX
    Zhen Ci Yan Jiu; 2009 Jun; 34(3):152-8. PubMed ID: 19761106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.
    Sáez-Valero J; Sberna G; McLean CA; Small DH
    J Neurochem; 1999 Apr; 72(4):1600-8. PubMed ID: 10098867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein.
    Kawabata S; Higgins GA; Gordon JW
    Nature; 1991 Dec; 354(6353):476-8. PubMed ID: 1793460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy.
    Deng M; Huang L; Ning B; Wang N; Zhang Q; Zhu C; Fang Y
    Brain Res; 2016 Dec; 1652():188-194. PubMed ID: 27737765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-β plaques in human brain tissue.
    Reid GA; Darvesh S
    Chem Biol Interact; 2024 May; 395():111012. PubMed ID: 38648920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease.
    Small DH; Moir RD; Fuller SJ; Michaelson S; Bush AI; Li QX; Milward E; Hilbich C; Weidemann A; Beyreuther K
    Biochemistry; 1991 Nov; 30(44):10795-9. PubMed ID: 1718425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.
    Lüth HJ; Holzer M; Gärtner U; Staufenbiel M; Arendt T
    Brain Res; 2001 Sep; 913(1):57-67. PubMed ID: 11532247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in molecular isoform distribution of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid beta-peptide.
    Sáez-Valero J; de Ceballos ML; Small DH; de Felipe C
    Neurosci Lett; 2002 Jun; 325(3):199-202. PubMed ID: 12044655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.
    Chigurupati S; Madan M; Okun E; Wei Z; Pattisapu JV; Mughal MR; Mattson MP; Chan SL
    J Alzheimers Dis; 2011; 24(2):349-61. PubMed ID: 21258150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
    Sáez-Valero J; Fodero LR; Sjögren M; Andreasen N; Amici S; Gallai V; Vanderstichele H; Vanmechelen E; Parnetti L; Blennow K; Small DH
    J Neurosci Res; 2003 May; 72(4):520-6. PubMed ID: 12704813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease.
    Rockenstein EM; McConlogue L; Tan H; Power M; Masliah E; Mucke L
    J Biol Chem; 1995 Nov; 270(47):28257-67. PubMed ID: 7499323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
    Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
    Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease.
    Chang KA; Suh YH
    J Pharmacol Sci; 2005 Apr; 97(4):461-71. PubMed ID: 15821343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.